Journal
JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 106, Issue 12, Pages 3413-3420Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.xphs.2017.08.009
Keywords
blood-brain tumor barrier; CNS delivery; nanoparticulate delivery vectors; clinical translation
Funding
- Outstanding Youth Foundation from Department of Science and Technology, Jilin Province [20170520046JH]
- Start-Up Research Grant Program from Jilin University [451160102052]
- EU Erasmus Programme
Ask authors/readers for more resources
Brain cancers are among the most lethal tumors due to their rapid development and poor prognosis. Despite the existing potential of novel therapeutic strategies for the treatment of brain cancer, the major remaining challenge associated with clinical translation is the lack of effective and safe delivery strategies to ensure drug transport to tumor tissues following systemic administration. Folate receptors, known to overexpress on different types of cancer cells, have been used to develop targeted delivery of therapeutic agents for cancer therapy. In this review, the potential of exploiting the folate receptor to achieve targeted cell-specific delivery of nanoparticles containing brain cancer therapeutics will be discussed in tandem with an analysis of the possible reasons for the current lack of clinical translation. (C) 2017 Published by Elsevier Inc. on behalf of the American Pharmacists Association.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available